Cargando…

Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection

BACKGROUND: Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50–80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-specific T cells predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Söderholm, Jonas, Waldenström, Jesper, Askarieh, Galia, Pilli, Massimo, Bochud, Pierre-Yves, Negro, Francesco, Pawlotsky, Jean-Michel, Zeuzem, Stefan, Ferrari, Carlo, Norkrans, Gunnar, Wejstål, Rune, Westin, Johan, Neumann, Avidan U., Haagmans, Bart L., Lindh, Magnus, Missale, Gabriele, Hellstrand, Kristoffer, Lagging, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577643/ https://www.ncbi.nlm.nih.gov/pubmed/23437290 http://dx.doi.org/10.1371/journal.pone.0056991

Ejemplares similares

Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
por: Lagging, Martin, et al.
Publicado: (2011)

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
por: Alsiö, Åsa, et al.
Publicado: (2012)

Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
por: Alestig, Erik, et al.
Publicado: (2011)

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations
por: Lagging, Martin, et al.
Publicado: (2016)

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Transient Elastography in Chronic Hepatitis C Infection
por: Ydreborg, Magdalena, et al.
Publicado: (2013)

The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection
por: Waldenström, Jesper, et al.
Publicado: (2020)

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3
por: Rembeck, Karolina, et al.
Publicado: (2012)

Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus
por: Nyström, Kristina, et al.
Publicado: (2018)

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
por: Waldenström, Jesper, et al.
Publicado: (2016)

Abundance of Noncircular Intrahepatic Hepatitis B Virus DNA May Reflect Frequent Integration Into Human DNA in Chronically Infected Patients
por: Rydell, Gustaf E, et al.
Publicado: (2020)

Heterologous T cell immunity in severe hepatitis C virus infection
por: Urbani, Simona, et al.
Publicado: (2005)

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study
por: Söderholm, Jonas, et al.
Publicado: (2019)

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
por: Bezemer, Geert, et al.
Publicado: (2012)

Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study
por: Büsch, Katharina, et al.
Publicado: (2020)

No need to discontinue hepatitis C virus therapy at the time of liver transplantation
por: Skoglund, Catarina, et al.
Publicado: (2019)

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis
por: Ydreborg, Magdalena, et al.
Publicado: (2014)

Genetic diversity of hepatitis C virus in Ethiopia
por: Hundie, Gadissa Bedada, et al.
Publicado: (2017)

Extrahepatic manifestations in hepatitis C virus infection
por: Negro, Francesco, et al.
Publicado: (2017)

Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection
por: Larsson, Simon B., et al.
Publicado: (2015)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
por: Chevaliez, Stéphane, et al.
Publicado: (2006)

Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report
por: Waldenström, Jesper, et al.
Publicado: (2015)

PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
por: Rembeck, Karolina, et al.
Publicado: (2012)

Hepatitis B Virus RNA Profiles in Liver Biopsies by Digital Polymerase Chain Reaction
por: Prakash, Kasthuri, et al.
Publicado: (2020)

COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2022)

New Antiviral Agents for Hepatitis C
por: Pawlotsky, Jean-Michel
Publicado: (2012)

High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles
por: Prakash, Kasthuri, et al.
Publicado: (2018)

Hepatitis C virus
por: Plagemann, P. G. W.
Publicado: (1991)

euHCVdb: the European hepatitis C virus database
por: Combet, Christophe, et al.
Publicado: (2007)

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection
por: Feld, Jordan J., et al.
Publicado: (2016)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
por: Shih, Yi-Fen, et al.
Publicado: (2020)

Hepatitis C virus and hepatitis B virus in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
por: Negro, Francesco
Publicado: (2009)

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
por: Weiler, Nina, et al.
Publicado: (2016)

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
por: Scott, Jane, et al.
Publicado: (2014)

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

Recombination in Hepatitis C Virus
por: González-Candelas, Fernando, et al.
Publicado: (2011)

Hepatitis C virus and hepatocarcinogenesis
por: Jeong, Soung Won, et al.
Publicado: (2012)

Hepatitis C virus and autoimmunity
por: Böckle, Barbara C., et al.
Publicado: (2010)

Virology of hepatitis C virus
por: Simmonds, Peter
Publicado: (1996)

Hepatitis B virus and hepatitis C virus in pregnant Sudanese women
por: Elsheikh, Rasha M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6a77ai6a00huma15id0qjrcffi